Skip to content

A clinical study to assess the influence of Tongluo Recipe on patients in convalescent stage of ischemic stroke: a randomized controlled trial

A clinical study to assess the influence of Tongluo Recipe on patients in convalescent stage of ischemic stroke: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004440
Enrollment
Unknown
Registered
2020-11-07
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Sponsors

Putuo Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who accord with Western and traditional Chinese medicine diagnostic criteria for ischemic stroke; 2. Patients with early stage of convalescence that is from 2 weeks to 3 months after stroke onset; 3. Aged from 45-80 years; 4. Patients with first attack, or re-attack and the former stroke is basically recovery with no sequel; 5. Patients with NIHSS score 7-22; 6. Be volunteer to participate in clinical trial; 7. Sign the written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with ischemic stroke induced by confirmed brain trauma, tumor, parasitosis, blood disease, heart disease, metabolic disorder, et al; 2. Patients with consciousness or language disorder affecting communication; 3. Patients with limbs activity disorder induced by joint and muscle damage affecting neurological examination; 4. Patients with severe disease including heart disease, hepatic disease, kidney disease, endocrine disease or hematopoietic disease, et al; 5. Pregnant and lactating women or mental patients; 6. Patients allergic to the ingredients contained in the Chinese medicine adopted in this clinical trial; 7. Patients participating in the other clinical trial at the same time.

Design outcomes

Primary

MeasureTime frame
FMA;NIHSS;MoCA;inflammatory factor detection;MRI examination;

Secondary

MeasureTime frame
BI;TCM symptom score;MMSE;serum lipid, hemorheology and HCY test;

Countries

China

Contacts

Public ContactLu Yu

Putuo Hospital, Shanghai University of Traditional Chinese Medicine

laurieyu@sohu.com+86 13918383386

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026